Abstract
Objective Systematically evaluate the risk prediction model for neonatal necrotizing enterocolitis (NEC) in China, providing reference for clinical work and future research.
Methods We searched Chinese and English databases were systematically searched to focus on NEC risk prediction modeling studies.The search time ranged from database establishment to 25 August 2023.Two researchers independently screened the literature and extracted information.Then risk of bias and applicability were assessed by using the Prediction Model Risk of Bias Assessment Tool.
Results A total of 10 papers involving 12 NEC risk prediction models were included, which is focusing on the populations of preterm infants mostly, building the methods of models diversity, predicting factors discrepancy widely.
conclusion The existing NEC risk prediction models in China have good predictive performance, while they often lack external validation, resulting in an overall high risk of bias. In the future, clinicians and nurses should learn from the evaluation criterions based on the PROBAST, then to test and verify them. Or machine learning algorithms usage is to construct models with operationalization and better predictive efficacy. [REGISTRATION: PROSPERO ID: CRD42024503844]
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
School of Nursing, Yunnan University of Chinese Medicine
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
